Home Ingredients Salba® / Premium Chia (Salvia hispanica — AHD International)
Cardiovascular

Salba® / Premium Chia (Salvia hispanica — AHD International)

Salvia hispanica
Evidence Level
Limited
1 Clinical Trial
7 Documented Benefits
2/5 Evidence Score

Salba® / Premium Chia from AHD International is a standardized chia seed ingredient (Salvia hispanica) selected for consistent omega-3 (alpha-linolenic acid), fiber, and protein content. Long history of traditional Aztec/Mayan use as foundational food crop. Used for: omega-3 ALA intake, dietary fiber and protein in the diet, and satiety. The human trial evidence is thin and centers on blood fats and blood pressure, where results have been inconsistent. Nothing published tests chia for hydration.

Studied Dose 1 to 2 tablespoons (10 to 25 g) daily as a food; the trials that reported a blood pressure change used about 37 to 40 g per day
Active Compound Whole chia seeds — omega-3 ALA (alpha-linolenic acid), soluble + insoluble fiber, protein

Benefits

Highest Plant Omega-3 ALA Content

Chia is one of the richest plant sources of the omega-3 fat alpha-linolenic acid (ALA), with roughly 60 percent of its fat as ALA. Flaxseed is comparable or higher per gram, so this is one good source among several rather than the single best. Note: ALA conversion to EPA/DHA is limited in humans (~5-10%).

Supported by Trial 1

Soluble + Insoluble Fiber (~30% Fiber)

Chia provides both soluble fiber (forms gel when hydrated) and insoluble fiber. Approximately 30% of weight is fiber.

Supported by Trial 1

Hydration Support

Chia soaks up many times its weight in water and forms a thick gel. That is a physical property of the seed measured in a glass, not a measured effect in people. No human study has tested whether eating chia improves hydration status or releases water during exercise. The exercise trials that have been published, including a half chia sports drink compared with a plain one and a two week trial of milled chia in trained cyclists, found no performance advantage, and none of them measured fluid balance.

Supported by Trial 1

Plant Protein Source

Approximately 15-20% protein; complete protein with all essential amino acids; suitable for plant-based diets.

Satiety / Weight Management

The gel chia forms adds bulk to a meal, which is the usual explanation for its filling effect. Where body weight has actually been measured, the effect is small and shows up only alongside a calorie-reduced diet, and several trials found no weight change at all. Treat chia as a filling addition to meals rather than a weight-loss agent.

Supported by Trial 1

Cardiovascular Health Profile

Chia has been tested for cardiovascular risk factors in people and the results are inconsistent. A meta-analysis of ten randomized trials found no statistically significant change in total cholesterol, triglycerides or LDL, and a systematic review of seven trials concluded the evidence is insufficient. What does repeat is a rise in blood ALA and EPA, and two small trials found lower systolic blood pressure.

Supported by Trial 1

Mineral Content

Provides calcium (notable for plant source), magnesium, phosphorus, manganese, iron.

Mechanism of action

1

Omega-3 ALA Pathway

Plant omega-3 (ALA) requires conversion to EPA and DHA — conversion is limited in humans (5-10%); some omega-3 benefits via direct ALA effects.

2

Soluble Fiber Gel Formation

Chia mucilage forms a gel in the stomach and gut. The proposed consequences are a fuller feeling, slower absorption of nutrients and softer, bulkier stool. These are mechanism-level ideas; none of the studies cited on this page measured bowel habits or digestive symptoms.

3

Whole Food Nutrition

Comprehensive nutrient profile vs. isolated supplements; minerals, vitamins, antioxidants in matrix.

Clinical trials

1
Systematic Review of Chia Seed and Cardiovascular Risk Factors (7 trials)
PubMed

de Souza Ferreira 2015, Nutricion Hospitalaria. A systematic review without meta-analysis covering seven human clinical trials of whole or milled chia seed, looking at lipids, blood pressure, blood sugar, body mass and inflammatory markers.

Adults across seven trials, 200 participants in total; five trials were blinded and two were single-dose acute studies.

Most of the seven trials did not produce statistically significant results for cardiovascular risk factors, and the authors state that chia has not been established as effective and that the evidence is insufficient. In four of the trials, blood ALA and EPA rose with no significant change in anything else. One trial showed lower systolic blood pressure and inflammatory markers with no change in body mass, lipids or blood sugar. In the two acute trials, blood sugar after a meal was lower. Two of the seven were rated at high risk of bias because they did not report all of their pre-specified primary outcomes.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GI distress (gas, bloating) common during fiber adjustment.
Choking and esophageal obstruction: never swallow dry chia seeds. They start forming a gel the moment they meet liquid and have caused complete blockage of the esophagus requiring emergency endoscopy. In the published case the man swallowed a tablespoon of dry seeds with a glass of water, so washing them down is not enough protection. Soak the seeds in liquid until fully gelled before eating, and avoid dry seeds entirely if you have any difficulty swallowing or a known narrowing of the esophagus.
Allergic reactions to chia possible (rare but increasing).
Theoretical bleeding effects from omega-3 at very high intake.

Important Drug interactions

Anticoagulants — modest theoretical effects from omega-3 ALA at high intake.
Antihypertensives — modest BP effects.
Diabetes medications — modest hypoglycemic effects from fiber.
Pregnancy: chia eaten as a food is generally considered safe, but concentrated supplemental doses have not been studied in pregnancy, so ask your clinician first.
Lactation — generally safe.
Children — generally safe at proportional amounts; whole seeds may need preparation for young children.

More Cardiovascular Ingredients

Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
CoroWise® (Plant Sterols for Cholesterol — Cargill)
CoroWise is Cargill's brand of plant sterols (phytosterols), which carry an FDA-authorized…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
CoEnzyme Q10
Coenzyme Q10 (CoQ10) is a lipid-soluble compound essential to mitochondrial ATP production…

Frequently asked questions about Salba® / Premium Chia (Salvia hispanica — AHD International)

What is Salba / Premium Chia?

Salba® / Premium Chia from AHD International is a standardized chia seed ingredient (Salvia hispanica) selected for consistent omega-3 (alpha-linolenic acid), fiber, and protein content. Long history of traditional Aztec/Mayan use as foundational food crop.

What is Salba / Premium Chia used for?

Salba / Premium Chia is researched primarily for Cardiovascular. Chia is one of the richest plant sources of the omega-3 fat alpha-linolenic acid (ALA), with roughly 60 percent of its fat as ALA.

What is the recommended dosage of Salba / Premium Chia?

The clinically studied dose is 1 to 2 tablespoons (10 to 25 g) daily as a food; the trials that reported a blood pressure change used about 37 to 40 g per day Always follow the product label and check with a healthcare provider for personal advice.

Is Salba / Premium Chia safe, and does it have side effects?

For most healthy adults, Salba / Premium Chia is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. GI distress (gas, bloating) common during fiber adjustment. It may also interact with some medications. Salba / Premium Chia is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Salba / Premium Chia interact with any medications?

Possible interactions include: Anticoagulants — modest theoretical effects from omega-3 ALA at high intake. Antihypertensives — modest BP effects. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Salba / Premium Chia?

NutraSmarts rates the evidence for Salba / Premium Chia as Limited (2 out of 5). It is backed by 1 clinical trial and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Silva LA, Verneque BJF, Mota APL, Duarte CK Chia seed (Salvia hispanica L.) consumption and lipid profile: a systematic review and meta-analysis Food & Function. 2021;12(19):8835-8849. doi: 10.1039/d1fo01287h.PubMedUsed to support: Systematic review and meta-analysis of 10 RCTs in which none of the pooled lipid results reached statistical significance. Total cholesterol (95% CI -9.98 to 4.02), triglycerides (95% CI -33.46 to 5.28) and LDL (95% CI -5.05 to 9.19) all cross zero. What the pooling did show consistently is a shift in blood fatty acid composition, with higher PUFA, ALA and EPA. The authors describe the effect on the lipid profile as neutral or beneficial, which is not the same as proven. Supports the statement that chia raises blood ALA and EPA. It did not measure satiety or body weight, so it cannot support those claims. On chia (Salvia hispanica) as a compound; Salba® is a standardized commercial cultivar.
  2. Alwosais EZM, Al-Ozairi E, Zafar TA, Alkandari S Chia seed (Salvia hispanica L.) supplementation to the diet of adults with type 2 diabetes improved systolic blood pressure: A randomized controlled trial Nutrition and Health. 2021;27(2):181-189. doi: 10.1177/0260106020981819.PubMedUsed to support: 12-week RCT in 42 adults with type 2 diabetes showing 40 g/day chia significantly reduced systolic blood pressure (p=0.007) vs controls. Supports the cardiovascular benefit only, and with reservations: there was no placebo, the control group simply took no supplement, and no other measure changed (fasting glucose, HbA1c, lipids, body weight and C-reactive protein were all unchanged versus control). Nothing in this trial has any bearing on hydration. On Salvia hispanica chia as a compound.
  3. Grancieri M, Martino HSD, Gonzalez de Mejia E Chia Seed (Salvia hispanica L.) as a Source of Proteins and Bioactive Peptides with Health Benefits: A Review Comprehensive Reviews in Food Science and Food Safety. 2019;18(2):480-499. doi: 10.1111/1541-4337.12423.PubMedUsed to support: A review that catalogued 20 chia proteins from the UniProt database and screened their amino acid sequences against the BIOPEP database. The antioxidant, ACE-inhibiting and DPP-IV-inhibiting activities it reports are computational predictions from those sequences, not effects measured in people, and the authors state the link needs further investigation in vitro and in vivo. The 20 percent figure in that paper refers to omega-3 fat content, not protein. Supports Plant Protein Source benefit and underscores chia's nutritional profile breadth (fiber, omega-3, protein). On Salvia hispanica as a compound.
  4. de Souza Ferreira C, Sousa Fomes Lde F, da Silva GE, Rosa G Effect of Chia Seed (Salvia hispanica L.) Consumption on Cardiovascular Risk Factors in Humans: A Systematic Review Nutricion Hospitalaria. 2015;32(5):1909-18. doi: 10.3305/nh.2015.32.5.9394.PubMedUsed to support: Systematic review of 7 human clinical trials showing chia consumption increases ALA and EPA omega-3 fatty acids in blood, in four of the seven trials. One trial showed a fall in systolic blood pressure and one showed a fall in triglycerides, and in that second trial the chia was mixed with other foods, so the drop cannot be credited to chia alone. Supports the omega-3 ALA content statement. The review's own conclusion is blunt: most of the included studies did not show statistically significant results, chia has not been established as effective for cardiovascular risk factors, and the authors call the evidence insufficient. On chia as a compound.